<DOC>
	<DOCNO>NCT02769299</DOCNO>
	<brief_summary>The overall objective proposal determine utility sensitive imaging biomarker measure detect subclinical cardiotoxicity across spectrum radiation dose heart . We focus specifically patient receive photon proton chest radiotherapy . Our broad work hypothesis RT induce early , subclinical CV injury , evidence cardiomyocyte inflammation necrosis , worsen CV function .</brief_summary>
	<brief_title>Cardiotoxicity Radiation Therapy ( CTRT )</brief_title>
	<detailed_description />
	<mesh_term>Cardiotoxicity</mesh_term>
	<criteria>Age 18 year old . Patients leave sided breast cancer newly initiate fractionate whole breast/chest wall regional nodal photon proton radiation therapy . Patients right side breast cancer newly initiate fractionate photon proton radiation therapy mediastinal nodal proton photon radiation therapy include cardiac dose . Lung cancer patient treat definitive intent ( great equal 50 Gy ) use fractionate thoracic radiotherapy proton photon radiation therapy . Patients receive concurrent chemotherapy allow . Patients mediastinal lymphoma , whose low extent mediastinal disease level carina , treat consolidative radiation definitive intent ( great equal 20 Gy ) use fractionate thoracic radiotherapy proton photon radiation therapy . Ability read comprehend English . Prior radiotherapy region study cancer would result overlap radiation therapy field Patients receive stereotactic body radiotherapy Patients unable undergo MR imaging exclude optional MR , exclude main study . Life expectancy le 12 month Vulnerable patient note 5 ( child , pregnant woman , fetus , neonate , prisoner ) Patients estimate glomerular filtration rate le 60 ml/min/1.73sq.m exclude optional MR , exclude main study . Nondiagnostic echocardiography window</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>